Doximity's partnership with Aledade — placing Ask and Scribe inside Aledade Assist, an EHR overlay for thousands of value-based primary care practices — demonstrates a principle that applies across clinical AI: tools become most valuable when they appear where clinicians already work, not when they exist as standalone destinations requiring separate navigation, separate login, separate cognitive context, and separate procurement.
Doximity described Ask as an evidence-backed clinical AI assistant and medical search engine validated through PeerCheck by 10,000+ physician authors, now available inside Aledade's workflow for thousands of independent-practice primary care clinicians. The partnership extends Doximity's clinical AI from its own platform into a partner's care environment — creating workflow adjacency that standalone reference tools cannot replicate.
The strategic logic is clear: clinical AI vendors should partner with workflow platforms to embed intelligence inside the care environment. The AI vendor provides the knowledge layer. The workflow partner provides distribution, clinical context, and the daily engagement that creates both clinical value and behavioural data.
Why Workflow Location Creates Structural Advantage
Clinical AI tools that sit inside the clinician's existing workflow have adoption advantages that standalone tools cannot overcome through superior content alone.
Lower friction. No separate login. No separate browser tab. No context switch. The tool appears within the interface the clinician is already using — reducing the activation energy from minutes to seconds. In a 10-minute GP consultation, the difference between a 30-second in-workflow query and a 2-minute separate-tool query is the difference between the tool being used and not being used.
Contextual relevance. The AI can surface information related to what the clinician is already doing — documentation, prescribing, referral, coding. Rather than requiring the clinician to formulate a separate query in a separate tool, the AI infers clinical context from the surrounding workflow and provides relevant information proactively or with minimal input.
Embedded habit formation. Tools that appear within daily workflow become part of the daily routine — generating the repeated use that creates both clinical value (better-informed decisions) and behavioural data (aggregate query patterns that feed insight products). Standalone tools compete for attention in every micro-moment of the clinical day. Embedded tools do not need to compete because they are already present.
Enterprise procurement alignment. Workflow-embedded tools can be deployed through existing vendor relationships and platform agreements — reducing the procurement friction that standalone tools face. In NHS contexts, where each new tool requires separate governance approval (DPIA, clinical safety case, IG assessment), embedding within an already-approved platform significantly reduces the procurement barrier.
Data continuity. When clinical AI sits inside the workflow, it can capture richer context about how clinical information is used — not just what was asked, but when it was asked relative to documentation, prescribing, or referral actions. This creates more valuable behavioural data for insight products (DocInsight, iatroX Insights) than standalone query data alone.
What iatroX Can Offer UK Partners
iatroX Insights offers UK partners custom clinical AI projects that apply the workflow-location principle within UK healthcare — with the regulatory, governance, and clinical safety considerations that UK deployment requires from day one.
NHS pilot design. Designing and supporting clinical AI pilots within NHS organisations — from initial scoping and governance preparation through deployment, evaluation, and outcome reporting. NHS pilots require specific preparation: clinical safety case (DCB 0129/0160), DPIA, IG assessment, clinical champion identification, staff training, patient communication strategy, outcome metrics, and evaluation methodology. iatroX Insights builds these requirements into the pilot design from the start.
Custom knowledge bases. Building guideline-aligned clinical AI retrieval for specific therapeutic areas, clinical workflows, or organisational knowledge requirements. A partner who needs AI that retrieves from a specific guideline set, formulary, shared-care protocol library, or clinical pathway collection can commission a custom knowledge base built with iatroX's retrieval and fidelity architecture — ensuring source grounding, citation visibility, and fail-safe behaviour.
Clinician validation sprints. Structured evaluation of clinical AI products by UK healthcare professionals — assessing accuracy, usability, trust, workflow fit, and clinical appropriateness. Not a satisfaction survey. A structured validation methodology with defined clinical scenarios, independent evaluation criteria, and actionable findings that help product teams understand UK clinician expectations before scaling. Validation sprints produce reports with clinical credibility — useful for marketing, procurement bids, and investor due diligence.
Educational partnerships. Developing CPD-linked clinical AI educational content, exam preparation modules, or guideline-aligned learning workflows. Partners who want to integrate clinical education with AI-supported learning can use iatroX's Q-bank infrastructure (15+ exams), CPD logging, calculator platform, and clinical AI capabilities as the foundation for co-developed educational products.
Market-entry projects. Supporting international healthtech companies entering the UK market. MHRA classification assessment, DTAC readiness review, DCB 0129/0160 clinical safety case development, NHS procurement preparation, UK claims review, guideline localisation, and clinician validation — a comprehensive market-entry service for companies whose products were designed for other healthcare systems.
Why Regulatory Thinking Cannot Be an Afterthought
Unlike generic AI features, UK clinical tools need intended-purpose discipline from the start. MHRA classification depends on intended use — getting this wrong (or failing to assess it) creates regulatory exposure that is expensive and time-consuming to remediate after launch. Clinical safety cases require systematic hazard identification and risk management built into product development — not documentation created after the product is finished. DTAC assessment covers clinical safety, data protection, technical security, interoperability, and usability — a comprehensive checklist that NHS organisations increasingly require before procurement conversations can even begin.
Partners who build regulatory thinking into the product from day one reach NHS adoption readiness months earlier than competitors who treat compliance as an afterthought — and avoid the costly, demoralising process of retrofitting governance into a product that was designed without it.
Explore a custom iatroX partnership or clinical AI project →